Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs ACWI✓SelectedUSD · ACWIGSK vs ACWI performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs ACWI

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+105.2%
ACWI return
+224.5%
Excess return
-119.2%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioACWIExcessAlpha
1D+0.5%-0.3%+0.8%+0.7%
7D+1.1%+2.4%-1.3%-0.2%
30D+6.3%-1.7%+8.0%+7.2%
3M+1.8%-3.9%+5.7%+3.9%
6M+1.7%+0.8%+0.9%+0.8%
YTD+6.5%+11.0%-4.5%0.0%
1Y+9.5%+13.1%-3.6%+1.7%
3Y+65.3%+73.9%-8.6%+18.9%
5Y+43.7%+59.0%-15.3%+8.0%
All+105.2%+224.5%-119.2%-6.0%

Cumulative growth

Daily Returns

Daily percentage return beside ACWI.

Daily Out/Under-Performance

Portfolio return minus ACWI return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ACWI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded ACWI wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling